The following guidance aligns with the manufacturer's instructions and Forum for Injection Technique (FIT UK) recommendations
Glucagon receptor activity can increase energy expenditure, push the liver toward fat oxidation, and raise lipid turnover
Your surgery team will remove it before you wake up
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns
Phase II detoxification enzymes and antioxidant proteins show enhanced expression[8]